<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Portfolio - Breast Invasive Carcinoma Research</title>
  <link rel="stylesheet" href="/assets/css/style.css">
</head>
<body>
  <header class="project-header">
      <h1>Breast Invasive Carcinoma Research Project</h1>
      <p class="subtitle">Genomics & Clinical Data Analysis | TCGA Dataset Study (BMEG 310)</p>
  </header>

  <nav>
    <a href="/index.html">Home</a>
    <a href="/experience.html">Experience & Education</a>
    <a href="/projects.html" class="active">Projects</a>
    <a href="/misc.html">Miscellaneous</a>
    <a href="/contact.html">Contact</a>
  </nav>

  <main class="project-main">
    

    <section class="project-section">
      <h2>Background & Overview</h2>
      <p>
        This study investigates the genetic and clinical characteristics of breast cancer, focusing on mutations within BRCA genes. Utilizing data from The Cancer Genome Atlas (TCGA), the research employs unsupervised learning to identify highly transcribed genes and to analyze factors affecting patient survival outcomes. Key insights are gained into pathways critical for tumor growth, such as cell cycle regulation and NK cell-mediated cytotoxicity.
      </p>
    </section>

    <section class="project-section">
      <h2>1.0 Study Objectives</h2>
      <ul>
        <li>Identify frequently mutated genes.</li>
        <li>Examine the impact of these genes on biochemical pathways.</li>
        <li>Determine patient demographic characteristics influencing survival.</li>
        <li>Explore possible therapeutic targets through pathway dysregulation insights.</li>
      </ul>
    </section>

    <section class="project-section">
      <h2>2.0 Methodology</h2>
      <h3>2.1 Data Collection & Preprocessing</h3>
      <p>
        Three TCGA datasets (mutation, clinical, and RNA sequencing) were used. Preprocessing filtered for high-impact mutations. Analyses included:
      </p>
      <ul>
        <li><em>Kaplan-Meier Survival Analysis:</em> Survival by demographics.</li>
        <li><em>Mutation Analysis:</em> Mutation frequencies, oncoplots, clustering.</li>
        <li><em>Differential Expression Analysis:</em> Gene expression differences across clusters.</li>
      </ul>
      <figure>
        <img src="/assets/img/BRCA/Cbioportalimage.JPG" alt="Cbioportal" class="project-img">
        <figcaption>Img 1: cBioPortal mutation view</figcaption>
      </figure>

      <h3>2.2 Clustering & Pathway Analysis</h3>
      <p>
        Patients were clustered into four groups by mutation profiles. Clusters were compared across demographics, clinical outcomes, and pathway activity.
      </p>
    </section>

    <section class="project-section">
      <h2>3.0 Results</h2>

      <h3>3.1 Clinical Summary</h3>
      <ul>
        <li><em>Demographics:</em> Most patients were White females, with subtype variation.</li>
        <figure>
          <img src="/assets/img/BRCA/image22.png" alt="Patient demographics" class="project-img">
          <figcaption>Img 2: Patient demographics</figcaption>
        </figure>
        <figure>
          <img src="/assets/img/BRCA/image16.png" alt="Subtypes" class="project-img">
          <figcaption>Img 3: Patient subtype distribution</figcaption>
        </figure>
        <li><em>Survival Outcomes:</em> Significant subtype differences, with worse outcomes in African American patients with Basal subtype.</li>
      </ul>
      <figure>
        <img src="/assets/img/BRCA/image32.png" alt="Survival outcomes" class="project-img">
        <figcaption>Img 4: Kaplan-Meier survival curves</figcaption>
      </figure>

      <h3>3.2 Mutation Analysis</h3>
      <p>
        Frequent mutations occurred in <strong>PIK3CA, TP53, and TTN</strong>, with missense mutations most common. Oncoplots highlighted four mutation-based clusters.
      </p>
      <figure>
        <img src="/assets/img/BRCA/image33.png" alt="Oncoplot" class="project-img">
        <figcaption>Img 5: Oncoplot of mutation clusters</figcaption>
      </figure>

      <h3>3.3 Pathway Findings</h3>
      <ul>
        <li><em>Cell Cycle:</em> Downregulated in some clusters, reflecting tumor growth impact.</li>
        <figure>
          <img src="/assets/img/BRCA/image18.png" alt="Cell cycle" class="project-img">
          <figcaption>Img 6: Cell cycle pathway impact</figcaption>
        </figure>
        <li><em>NK Cell Cytotoxicity:</em> Varied across clusters, relevant for immunotherapy.</li>
        <figure>
          <img src="/assets/img/BRCA/image17.png" alt="NK cells" class="project-img">
          <figcaption>Img 7: NK cell cytotoxicity pathway</figcaption>
        </figure>
        <li><em>Antigen Processing:</em> Linked to immune response and potential therapy targets.</li>
        <figure>
          <img src="/assets/img/BRCA/image26.png" alt="Antigen pathway" class="project-img">
          <figcaption>Img 8: Antigen processing pathway</figcaption>
        </figure>
      </ul>
    </section>

    <section class="project-section">
      <h2>4.0 Discussion</h2>
      <ul>
        <li><em>Demographics:</em> Subtype differences across ethnic groups align with prior research.</li>
        <li><em>Therapeutic Implications:</em> NK cytotoxicity and cell adhesion molecules are promising therapy targets.</li>
      </ul>
    </section>

    <section class="project-section">
      <h2>5.0 Limitations</h2>
      <p>
        Hierarchical clustering struggled with overlapping gene activity between subtypes. Future studies should refine clustering methods for clearer subtype resolution.
      </p>
    </section>

    <section class="project-section">
      <h2>6.0 Conclusion</h2>
      <p>
        This study highlights genetic and pathway differences in breast invasive carcinoma. Findings suggest targeted therapies should consider subtype-specific pathway dysregulation.
      </p>
      <a href="/assets/pdfs/BRCAReport.pdf" class="download-btn" download>ðŸ“„ Download Full Report</a>
    </section>
  </main>

  <footer>
    <p>Â© 2025 My Portfolio | Designed by Me (á—’á—¨á—•)</p>
  </footer>
</body>
</html>
